Dudediligence.

Theravance Biopharma Inc

TBPHNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,860,368

6 notices · 163,263 sh

Nov 2025 to Oct 2026

Reported ·

$3,179,405

15 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

11 of 15 reported sales carry the 10b5-1 box. Together they are 0.35% of the shares on issue.

PLANNED · FORM 144Nov 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: RHONDA FARNUM, Form 1442026-06-15: RHONDA FARNUM, Form 1442026-03-16: RHONDA FARNUM, Form 1442025-12-03: RHONDA FARNUM, Form 1442025-11-26: ERAN BROSHY, Form 1442025-11-11: ERAN BROSHY, Form 1442025-11-11: BROSHY ERAN, sold2025-11-11: BROSHY ERAN, sold2025-11-26: BROSHY ERAN, sold2025-12-03: Farnum Rhonda, sold2026-03-16: Farnum Rhonda, sold2026-06-15: Farnum Rhonda, sold
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-09-15RHONDA FARNUM, SVP, COMM & MEDICAL AFFAIRS$226,793
13,314 shplan 2025-09-03Form 4s on file end Jun 23144 ↗
2026-06-15RHONDA FARNUM, SVP, COMM & MEDICAL AFFAIRS$218,167
13,314 shplan 2025-09-03144 ↗
Form 4, 2026-06-17: sold 13,314 at $16.39 Form 4 ↗
2026-03-16RHONDA FARNUM, SVP, COMM & MEDICAL AFFAIRS$433,637
31,067 shplan 2025-09-03144 ↗
Form 4, 2026-03-18: sold 31,067 at $13.96 Form 4 ↗
2025-12-03RHONDA FARNUM, SVP, COMM & MEDICAL AFFAIRS$582,500
31,067 shplan 2025-09-03144 ↗
Form 4, 2025-12-05: sold 31,067 at $18.75 Form 4 ↗
2025-11-26ERAN BROSHY, Director$590,020
29,501 shplan 2024-06-14144 ↗
Form 4, 2025-12-01: sold 29,501 at $20.00 Form 4 ↗
2025-11-11ERAN BROSHY, Director$809,250
45,000 shplan 2024-06-14144 ↗
Form 4, 2025-11-13: sold 59,000 at $18.11 Form 4 ↗